Navigating Change in Tumor Naming: Exploring the Complexities and Considerations of Shifting Toward Molecular Classifications-Reference-Cited by-同舟云学术

Navigating Change in Tumor Naming: Exploring the Complexities and Considerations of Shifting Toward Molecular Classifications

Published:2024-06-27 Issue: Volume: Page:
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ilié Marius¹^ORCID,Heeke Simon²^ORCID,Horgan Denis³,Hofman Paul¹^ORCID

Affiliation:

1. Laboratory of Clinical and Experimental Pathology, Hospital-Integrated Biobank (BB-0033-00025), IHU RespirERA, FHU OncoAge, University Hospital Centre Nice, University Côte d’Azur, Nice, France

2. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

3. European Alliance for Personalised Medicine, Brussels, Belgium

Abstract

Navigating change in tumor naming. Balance organ-based and molecular classifications for optimal treatment.

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.24.00323

Reference19 articles.

1. Forget lung, breast or prostate cancer: why tumour naming needs to change

2. The “New Normal” of Cancer Treatment Delays Is Nothing New

3. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

4. Structure-based classification predicts drug response in EGFR-mutant NSCLC

5. Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development;Annals of Oncology;2024-08